STUDY OBJECTIVES: To determine the effect of mild vs severe Parkinson's disease on objective sleep parameters, in a subgroup of patients with subjective excessive daytime somnolence. DESIGN: Patients with either mild (Hoehn and Yahr stage 1 or 2) or severe (Hoehn and Yahr stage 4 or 5) idiopathic Parkinson's disease and subjective evidence of sleepiness (Epworth sleepiness scale > 8) were recruited. All patients underwent overnight polysomnography autonomic function testing and completed questionnaires assessing quality of life, mood, and drug dosages. Mild and severe groups were then compared using the paired t-test for normally distributed data and the Mann-Whitney U test for nonparametric data. SETTING: Accredited sleep centre and neurosciences unit at tertiary referral centre. PATIENTS OR PARTICIPANTS: Parkinson's disease outpatients referred by their treating neurologist. INTERVENTIONS: N/A. RESULTS: 11 patients with mild disease and 7 with severe disease were studied. Both groups slept poorly when compared to historic normal controls. Their sleep efficiency was decreased, and the architecture fragmented. However, there was no significant difference in objective sleep parameters between the two groups. There was a significant increase in the number of voids overnight in the severe disease group (p< 0.05). CONCLUSIONS: In this subgroup of patients with subjective excessive day-time somnolence, the severity of Parkinson's disease was not associated with a change in the measured sleep parameters. Other factors, such as drug effects, may have played a greater role. Alternatively, motor/functional measures of disease severity may poorly reflect the level of sleep disturbance. Nocturia is an important factor which disturbs sleep, particularly in the severe disease group.
STUDY OBJECTIVES: To determine the effect of mild vs severe Parkinson's disease on objective sleep parameters, in a subgroup of patients with subjective excessive daytime somnolence. DESIGN:Patients with either mild (Hoehn and Yahr stage 1 or 2) or severe (Hoehn and Yahr stage 4 or 5) idiopathic Parkinson's disease and subjective evidence of sleepiness (Epworth sleepiness scale > 8) were recruited. All patients underwent overnight polysomnography autonomic function testing and completed questionnaires assessing quality of life, mood, and drug dosages. Mild and severe groups were then compared using the paired t-test for normally distributed data and the Mann-Whitney U test for nonparametric data. SETTING: Accredited sleep centre and neurosciences unit at tertiary referral centre. PATIENTS OR PARTICIPANTS: Parkinson's disease outpatients referred by their treating neurologist. INTERVENTIONS: N/A. RESULTS: 11 patients with mild disease and 7 with severe disease were studied. Both groups slept poorly when compared to historic normal controls. Their sleep efficiency was decreased, and the architecture fragmented. However, there was no significant difference in objective sleep parameters between the two groups. There was a significant increase in the number of voids overnight in the severe disease group (p< 0.05). CONCLUSIONS: In this subgroup of patients with subjective excessive day-time somnolence, the severity of Parkinson's disease was not associated with a change in the measured sleep parameters. Other factors, such as drug effects, may have played a greater role. Alternatively, motor/functional measures of disease severity may poorly reflect the level of sleep disturbance. Nocturia is an important factor which disturbs sleep, particularly in the severe disease group.
Authors: Camille P Vaughan; Jorge L Juncos; Lynn Marie Trotti; Theodore M Johnson; Donald L Bliwise Journal: Neurourol Urodyn Date: 2013-01-28 Impact factor: 2.696
Authors: Israt Jahan; Robert A Hauser; Kelly L Sullivan; Amber Miller; Theresa A Zesiewicz Journal: Neuropsychiatr Dis Treat Date: 2009-11-02 Impact factor: 2.570
Authors: Young Hee Sung; Hee Jin Kim; Seong Beom Koh; Joong Seok Kim; Sang Jin Kim; Sang Myung Cheon; Jin Whan Cho; Yoon Joong Kim; Hyeo Il Ma; Mee Young Park; Jong Sam Baik; Phil Hyu Lee; Sun Ju Chung; Jong Min Kim; In Uk Song; Han Joon Kim; Ji Young Kim; Do Young Kwon; Jae Hyeok Lee; Jee Young Lee; Ji Seon Kim; Ji Young Yun; Jin Yong Hong; Mi Jung Kim; Jinyoung Youn; Ji Sun Kim; Eung Seok Oh; Hui Jun Yang; Won Tae Yoon; Sooyeoun You; Kyum Yil Kwon; Hyung Eun Park; Su Yun Lee; Younsoo Kim; Hee Tae Kim; Tae Beom Ahn Journal: J Korean Med Sci Date: 2018-01-08 Impact factor: 2.153